The brain might become the target of new type 1 diabetes treatments and pave a better way for insulin management, according to a study. 

Researchers had, over a decade ago, found that an acute complication of type 1 diabetes -- diabetic ketoacidosis (DKA) -- can be resolved with the hormone leptin, even in the absence of insulin.

In the analysis, published in the Journal of Clinical Investigation, the team explained how leptin affects the brain and how it might be used in future therapeutics.